Ocrelizumab-Induced Severe Colitis
Joint Authors
Lee, Hsing Hwa
Sritharan, Naveen
Bermingham, Daniel
Strey, Gabriela
Source
Case Reports in Gastrointestinal Medicine
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-12-07
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy.
Histology of the colectomy was consistent with medication-induced colitis.
American Psychological Association (APA)
Lee, Hsing Hwa& Sritharan, Naveen& Bermingham, Daniel& Strey, Gabriela. 2020. Ocrelizumab-Induced Severe Colitis. Case Reports in Gastrointestinal Medicine،Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1147527
Modern Language Association (MLA)
Lee, Hsing Hwa…[et al.]. Ocrelizumab-Induced Severe Colitis. Case Reports in Gastrointestinal Medicine No. 2020 (2020), pp.1-4.
https://search.emarefa.net/detail/BIM-1147527
American Medical Association (AMA)
Lee, Hsing Hwa& Sritharan, Naveen& Bermingham, Daniel& Strey, Gabriela. Ocrelizumab-Induced Severe Colitis. Case Reports in Gastrointestinal Medicine. 2020. Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1147527
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1147527